Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VBLT

Vascular Biogenics (VBLT) Stock Price, News & Analysis

Vascular Biogenics logo

About Vascular Biogenics Stock (NASDAQ:VBLT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.16
$5.46
52-Week Range
N/A
Volume
161,505 shs
Average Volume
2.19 million shs
Market Capitalization
$423.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VBLT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vascular Biogenics and its competitors with MarketBeat's FREE daily newsletter.

VBLT Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Notable Labs Closes Merger Transaction With VBL Therapeutics
Vascular Biogenics Rises on Presentation Hype
See More Headlines

VBLT Stock Analysis - Frequently Asked Questions

Vascular Biogenics Ltd. (NASDAQ:VBLT) posted its quarterly earnings data on Monday, November, 15th. The biopharmaceutical company reported ($0.09) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.11) by $0.02. The biopharmaceutical company earned $0.20 million during the quarter, compared to analysts' expectations of $0.20 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vascular Biogenics investors own include T2 Biosystems (TTOO), SCYNEXIS (SCYX), Onconova Therapeutics (ONTX), OPKO Health (OPK), VBI Vaccines (VBIV), TherapeuticsMD (TXMD) and Vaxart (VXRT).

Company Calendar

Last Earnings
11/15/2021
Today
7/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:VBLT
Previous Symbol
NASDAQ:VBLX
CIK
1603207
Employees
7
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.21)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$32.30 million
Net Margins
N/A
Pretax Margin
-3,317.05%
Return on Equity
-73.45%
Return on Assets
-54.11%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.63
Quick Ratio
4.63

Sales & Book Value

Annual Sales
$660 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.32 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
77,640,000
Free Float
72,881,000
Market Cap
$423.91 million
Optionable
Optionable
Beta
0.77

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:VBLT) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners